Tvardi Therapeutics (TVRD) Gross Profit (2022 - 2024)
Tvardi Therapeutics (TVRD) posted Gross Profit of $1.5 million for Q4 2024, down 43.08% sequentially from $2.6 million in Q3 2024, and down 39.27% YoY from $2.4 million in Q1 2024.
Tvardi Therapeutics (TVRD) Gross Profit (2022 - 2024) Analysis & Trends
Tvardi Therapeutics has reported Gross Profit for 3 years, with the latest figure at $1.5 million in Q4 2024.
- Quarterly Gross Profit fell 39.27% year-over-year to $1.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $6.5 million (down 55.95% YoY) and the FY2024 annual result came in at $6.5 million, down 55.95% from the prior year.
- Gross Profit declined to $1.5 million in Q4 2024 per TVRD's latest filing, from $2.6 million in the prior quarter.
- Over five years, Gross Profit peaked at $23.0 million in Q2 2022 and troughed at $991000.0 in Q2 2024.
- A 3-year average of $4.7 million and a median of $2.6 million in 2022 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2023 and 2024: Gross Profit soared 111.85% in 2023, then sank 82.03% in 2024.
- Over 3 years, Gross Profit stood at $1.1 million in 2022, then surged by 111.85% to $2.4 million in 2023, then tumbled by 39.27% to $1.5 million in 2024.
- According to Business Quant data, Gross Profit over the past three periods registered $1.5 million, $2.6 million, and $991000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tvardi Therapeutics | 17.36 Mn | 17.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.46 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 991,000.00 |
| Jun 30, 2024 | 991,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 2.40 Mn |
| Dec 31, 2023 | 2.40 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 5.52 Mn |
| Jun 30, 2023 | 5.52 Mn |
| Mar 31, 2023 | 3.58 Mn |
| Mar 31, 2023 | 3.58 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 7.76 Mn |
| Sep 30, 2022 | 7.76 Mn |